BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:indacaterol maleate / mometasone furoate readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of indacaterol maleate / mometasone furoate\
 , from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05562466-3771@assetmemo.bio
DTSTAMP:20261121T010022Z
DTSTART;VALUE=DATE:20280201
DTEND;VALUE=DATE:20280202
SUMMARY:indacaterol maleate / mometasone furoate: Phase 3 readout est. (NCT
 05562466)
DESCRIPTION:indacaterol maleate / mometasone furoate\, phase 3\, Asthma.\nS
 tudy: A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol A
 cetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Th
 an 12 Years of Age With Asthma\nEstimated primary completion: 1 February 2
 028. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\
 , and it can move.\nDrug page: https://assetmemo.bio/drug/indacaterol-male
 ate-mometasone-furoate#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT05562466
URL:https://assetmemo.bio/drug/indacaterol-maleate-mometasone-furoate#upcom
 ing-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
